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Abstract
Background: Outdoor air pollution, given its demonstrated negative effects on the respiratory system, is a growing
public health concern worldwide, particularly in urban cities. Human exposure to pollutants such as ozone,
nitrogen oxides, combustion-related particulate matter and oxides of sulfur is responsible for significant
cardiopulmonary morbidity and mortality in both adults and children. Several antioxidants have shown an ability to
partially attenuate the negative physiological and functional impacts of air pollutants. This study systematically
presents current data on the potential benefits of antioxidant supplementation on lung function outcomes
associated with air pollutant exposures in intact humans.
Methods: Electronic databases (MEDLINE, EMBASE, BIOSIS Previews, Web of Sciences, Environmental Sciences &
Pollution Management and TOXNET) were systematically searched for all studies published up to April 2009. Search
terms relating to the concepts of respiratory tract diseases, respiratory function tests, air pollution, and antioxidants
were used. Data was systematically abstracted from original articles that satisfied selection criteria for inclusion. For
inclusion, the studies needed to have evaluated human subjects, given supplemental antioxidants, under
conditions of known levels of air pollutants with measured lung function before and after antioxidant
administration and/or air pollution exposure. Selected studies were summarized and conclusions presented.
Results: Eight studies investigated the role of antioxidant supplementation on measured lung function outcomes
after subject exposure to air pollutants under controlled conditions; 5 of these studies concluded that pollutant-
induced airway hyper-responsiveness and diminution in lung function measurements were attenuated by
antioxidant supplementation. The remaining five studies took place under ambient (uncontrolled) exposures and
unanimously concluded that antioxidant supplementations attenuate the negative effects of urban air pollution on
lung function.
Conclusions: The data evaluating modification of changes in lung function associated with air pollutant exposure
by antioxidant supplementation, in intact humans, is limited. Of 13 studies dedicated to this concern, ten
demonstrated an attenuation of pollution-associated decrements. There is growing evidence for the benefit of anti-
oxidant supplementation in moderating the effects of air pollution on lung function, but more research on human
participants is needed to inform this topic.
Background
Outdoor air pollution, particularly that produced by vehi-
cle exhaust, has become a growing public health concern
worldwide. Outdoor particulate matter (PM) air pollution
is responsible for approximately 3% of adult cardiopul-
monary disease mortality, 5% of respiratory cancer
mortality, and 1% of mortality in children from acute
respiratory infection in urban areas worldwide [1]. Air
pollution can evoke symptoms in persons without under-
lying lung diseases and exacerbate symptoms in persons
with lung diseases such as asthma and chronic obstruc-
tive pulmonary disease. For example, one study in 208
children showed that exposure to PM 2.5 (PM with mean
aerodynamic diameter of 2.5 microns or less) for an aver-
age of 22 weeks resulted in acute airway inflammation
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FEV1 (P = 0.048), and Forced Vital Capacity, FVC (p =
0.012) [2]. Similar studies have also demonstrated the
negative effects of air pollution on lung function such as
statistically significant decrements in FEV1,F V C ,m i d
Forced Expiratory Flow (FEF25-75) and Peak Expiratory
Flow (PEF) [3-5].
Data support the association between imbalanced
oxidant homeostasis and lung disease including asthma
[6]. Deficiencies in antioxidants have been associated
with asthmatic severity and prevalence [7,8]. Further-
more, there is growing evidence for oxidative stress in
response to air pollution [9]. Constituents in traffic-
related air pollution, including quinones, aromatic
hydrocarbons, and transition metals, have the potential
to produce reactive oxygen species [10,11] and oxidative
stress [12-15]; some of these effects may therefore,
hypothetically, be reversible with antioxidants. A con-
trolled human exposure model has shown increases in
reduced glutathione levels (a sign of oxidative stress) in
the bronchial and nasal airways following exposure to
diesel exhaust [16]. Humans exposed to diesel exhaust
have decreased glutathione and urate levels and deple-
tion of glutathione is associated with the pathogenesis of
idiopathic pulmonary fibrosis [17]. Animal studies have
shown an increase in levels of antioxidant genes in
epithelial cells after exposure to diesel exhaust particles
[18].
However, there is a paucity of study regarding the
ability of supplemental antioxidants such as Vitamin C
and Vitamin E to prevent deterioration of lung function
or other phenomena associated with air pollution. In
addition, most literature on the current subject is based
on animal or in vitro studies, while the quintessential
proof of applicability necessitates human-based studies.
Animal-modelled studies are limited in applicability by
obvious physiological differences between the human
and animal model, making them significantly limited in
terms of public health recommendations. In vitro studies
such as that performed by Greenwell et al. [19] are
insightful but lack the direct evidence that is imperative
for implementation into public health guidelines.
Further, despite the informative nature of the broad lit-
erature and studies that investigate the effects of varying
basal (endogenous) antioxidant concentrations on pollu-
tant responsiveness [20], such studies are limited by
concerns over confounding in observational studies (i.e.,
concerns that those with higher endogenous antioxi-
dants are endowed with or prone to acquire beneficial
factors other than the observed differences in antioxi-
dants). Experimental studies, in which a single interven-
tion is precisely administered, are particularly persuasive
if an effect of the intervention is clearly observed.
Currently, there is particular interest on the role of
supplemental antioxidants in ameliorating pollution-
induced insults to the lung and a general recognition
that there is insufficient evidence for a strong recom-
mendation therein at this time [21]. The desire to best
understand the relevant evidence for such a recommen-
dation compelled this systematic review. Accordingly,
we decided to focus on studies that included direct mea-
surement of lung function, as changes in lung function
are most commonly appreciated as clinically relevant
whereas studies inclusive only of biomarkers may be
insightful but less compelling in terms of recommenda-
tions to the public. Similarly, this systematic review did
not evaluate studies that addressed the effects of endo-
genous antioxidants as modifiers of air pollution effects
[22] or studies that addressed the effects of air pollution
on altering endogenous antioxidant levels [23]; we have
focused on the effects of exogenous administration of
antioxidants, given the practical question of whether
such supplements are likely to ameliorate air pollution-
related respiratory health effects. In summary of the
above, the current review addresses the evidence for the
effects of antioxidant supplementation, in intact
humans, on changes in lung function associated with
measured levels of air pollution.
Methods
The systematic search strictly focused on the effects of
antioxidant supplementation in humans, both paediatric
and adult, with respect to lung function as an outcome
associated with quantified levels of air pollutants. Antioxi-
dant supplementation could be naturally-occurring or syn-
thetic, in any dose and form of administration, taken
individually or in combination, and compared to placebo
or to standard medication or care. Air pollutants were
identified as ozone, nitrogen oxides, combustion-related
particulate matter [excluding biomass and cigarette
smoke], and oxides of sulfur. In summary, for inclusion
t h ea r t i c l e sn e e d e dt oh a v ee v a l u a t e dh u m a ns u b j e c t s ,
given supplemental antioxidants, under conditions of
known levels of air pollutants (amongst those listed
above), with measured lung function before and after anti-
oxidant administration and/or air pollution exposure.
A ss h o w ni nF i g u r e1 ,s i n c et h er e s e a r c hq u e s t i o n
encompasses topics in medicine, public health and envir-
onmental studies, the literature search included appropri-
ate electronic databases. Peer-reviewed studies were
identified from MEDLINE (1950 to April Week 4 2009),
EMBASE (1980 to 2009 week 16), BIOSIS Previews (1969
to 2009), Web of Science (1965 to 2009 week 16), Envir-
onmental Sciences & Pollution Management (1967 to
2009 week 16), and TOXNET (1965 to 2009 week 16)
databases. Search terms related to the concepts of
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Page 2 of 11respiratory tract diseases, respiratory function tests, air
pollution, and antioxidants were used. They included
MeSH (Medical Subject Headings) and keywords related
to the concepts (Additional Files 1). Having developed
the above literature search strategies, the searches were
run on April 23, 2009.
Abstracts from this search were examined for dupli-
cates, which were removed; the remaining abstracts
 Six databases searched 
(EMBASE, n=1708; BIOSIS, n =1405; MEDLINE, n =713; Web of Science, n =523; 
TOXNET, n =1608; Environmental Sciences & Pollution Management, n =55) 
Potentially relevant studies identified 
through systematic searches 
(n=6012)
Articles and abstracts retrieved for full-
text review 
(n=64)
Articles included in qualitative synthesis 
(n=12)
Excluded (n=5948)
x Duplicate publications (n=2704)
x Not conforming to inclusion 
criteria based on electronic 
references & abstracts (n=3244)
Excluded studies (n=52)
x No supplementation given (n=19)
x Non-lung function outcome (n=9) 
x Review Article (n=20)
x In-vitro study (n=3)
x Non-human study (n=1) 
Figure 1 Flow chart of included studies.
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There were no restrictions on participant age, study
type or study language. Studies which investigated
related phenomena, but not strictly lung function, such
as exhaled nitric oxide [24] or medication use [25] were
excluded. The first stage involved screening electronic
abstracts. Authors CC and KC independently reviewed
the abstracts, implementing predetermined selection cri-
teria. Upon completion, both results were compared and
abstracts which were included in one author’s selection
l i s ta n dn o tt h eo t h e rw e r ee a c hd i s c u s s e da m o n g s tt h e
two authors. Upon review, abstracts were eliminated
only after a unanimous decision, or (if disagreement
remained) abstracts were kept for a full-text review.
Full-text of the articles was obtained for the remaining
abstracts and each was scrutinized applying the inclu-
sion criteria. Further, references from selected studies
were assessed for relevant articles, ensuring that the
search was comprehensive.
After the full-text review, a total of thirteen studies
consistent with our inclusion criteria were selected. One
paper [26] described two independent studies, each of
which met our specified criteria. Therefore, this paper
was treated as two separate studies in the summarizing
tables. Finally, selected studies were assigned to one of
two tables, depending on whether participants were sub-
ject to controlled pollution as represented in Table 1 or
ambient, uncontrolled (but measured) pollution condi-
tions as represented in Table 2.
Results
As illustrated by Figure 1, the original systematic search
of six databases, using appropriate key words, resulted
in 6012 literature entries. After duplicate studies were
removed, a total of 3308 abstracts remained for assess-
ment. After scanning abstracts to eliminate those not
conforming to inclusion criteria, 64 papers remained for
a full text analysis. After further scrutiny for conformity
to specified inclusion criteria by the two independent
reviewers, a total of 13 studies remained. Common rea-
sons for exclusion at this stage were lack of lung func-
tion measurements or investigation of endogenous as
opposed to supplemental antioxidants. The majority of
selected studies were from the United States (6 studies),
the Netherlands (3 studies) and Mexico (2 studies) with
an additional study from Sweden and one from Italy.
Vitamin C and ozone were the most common antioxi-
dant and pollutant among the selected studies, respec-
tively. Exposure length ranged from 45 minutes to 2
hours in the controlled conditions and from 2 hours to
6 months in the ambient pollution conditions. Tables 1
and 2 contain key information about the 13 studies that
fully met inclusion criteria, including study design, study
population, country and year of investigation, individual
study inclusion and exclusion criteria, and relevant
outcomes.
Table 1 summarizes eight studies that investigated the
effects of antioxidant supplementation on lung function
measurements, under controlled pollution conditions. Stu-
dies providing support for antioxidants, as well as those
lacking such support, are noted and we did not find any
evidence for publication bias. Five of the reported studies
concluded that pollutant induced airway hyper-responsive-
ness and diminution in lung function which were attenu-
ated by antioxidant supplementation. Mohsenin et al. [27]
exposed eleven healthy subjects to one hour of controlled
NO2 levels after vitamin C supplementation and reported
a 21% decrease in the dose of Metacholine required to
cause a 40% reduction (p < 0.04) in specific airway con-
ductance (SGaw) after NO2 exposure without supplemen-
tation. This study further concluded that airway
hypersensitivity induced by NO2 was almost entirely atte-
nuated by pre-treatment with ascorbic acid (p < 0.04),
relative to placebo. Peters et al. [28], in a similar study,
reached the same conclusion after subject supplementa-
tion with Apocynin inhalations; specifically, this study
concluded that Apocynin supplementation reduced the
maximal percent fall from baseline (ΔMFEV1:f a l li n
MFEV1 in response to two hours of ozone exposure) by
8.05%, compared to placebo (p = 0.025). Samet et al. [4]
and Chatham et al. [29] exposed subjects to ozone under
controlled conditions and after vitamin E and vitamin C
supplementations, and both studies concluded that ozone-
induced decrements in FVC were attenuated by these anti-
oxidants. After 2 hours of ozone exposure, Samet et al. [4]
o b s e r v e dt h a tt h eO 3-induced decreases in normalized
FVC and FEV1 values in the supplemented group were
24% (p = 0.046) and 30% (p = 0.055) smaller, respectively,
as compared with the placebo group; no significant effect
on FEV1, FEF25-75, and SGaw was noted by Chatham (p >
0.05) after 2 hours of ozone exposure, but the effects of
antioxidants on FVC was significant (p < 0.05). Finally,
Trenga et al. [5] subjected seventeen asthmatic adults to
45 minutes of controlled ozone and air exposures followed
by Sulfur dioxide challenge, after vitamin C and vitamin E
supplementation. All pulmonary function tests measured
were decreased significantly (p < 0.001) regardless of expo-
sure atmosphere (air or ozone). However, subjects that
were supplemented by Vitamin C & E responded less
severely to post ozone exposure sulphur dioxide challenge
than subjects given a placebo (FEV1: -1.2% vs. -4.4%,
respectively; PEF: +2.2% vs. -3.0%, respectively; FVC:
-2.15% vs. -2.51%, respectively, and FEF 25-75: +2.0% vs.
-4.3%, respectively), concluding that post ozone SO2-
induced decrements in lung function measurements were
attenuated by vitamin C and E supplementation.
Three studies failed to demonstrate such a moderating
effect of antioxidants. Mudway et al. [3] observed
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Page 4 of 11Table 1 Studies assessing effect of antioxidant supplementation on lung function associated with controlled air pollutant exposures in intact humans
First
author,
Year,
Country
Study design Conditions* Pollutant
exposure
duration
Additional
stresses
during
exposure
Population
(N)
Age
range
Inclusion / Exclusion criteria Outcome
Hackney,
1981, USA
Randomized
(non-crossover);
supplement double-
blinded; exposure
nominally single-
blinded
a) 800 IU Vitamin E (9 to 10
weeks); air then next-day
ozone (0.5 ppm)
2 hr Heat and
“light
exercise”
Healthy
(34)
20-27 Not Specified. No significant effect of antioxidants on
ozone-attributable decrease in FEV1 and
FVC. (i.e. statistical significance of
supplementation effect: p > 0.05).
b) Placebo (9 to 10 weeks);air
then next day ozone (0.5
ppm)
Hackney,
1981, USA
Randomized
(non-crossover);
supplement double-
blinded, exposure
nominally single-
blinded
a) 1600 IU Vitamin E (11 to 12
weeks); air then ozone (0.5
ppm, for 2 subsequent days)
2 hr Heat and
“light
exercise”
Healthy
males
(22)
22-28 Not Specified. No significant effect of antioxidants on
ozone-attributable decrease in FEV1, FVC,
TLC, FEF25%, FEF50% (i.e. statistical
significance of supplementation effect: p >
0.05).
b) Placebo (11 to 12 weeks);
air
then ozone (0.5 ppm, for 2
subsequent days)
Chatham,
1987, USA
Randomized
(crossover); double-
blinded
a) Vitamin C (1 gm, one hour
before exposure) and Vitamin
E (800 IU daily for unspecified
duration); ozone (0.3 ppm)
2 hr Exercise Medical
students
(9)
21-29 Normal baseline pulmonary
function, non-smokers, refrained
from any drugs, including vitamin
supplements.
Ozone-induced decrements in FVC were
attenuated by vitamin C and vitamin E (p <
0.05), but no significant effect was observed
in FEV1, FEF25-75 and SGaw (p > 0.05).
b) Placebo; Ozone (0.3 ppm)
Mohensin,
1987, USA
Randomized
(crossover); double-
blinded
a) Vitamin C (2000 mg/day for
3 days); NO2 (2.0 ppm)
1 hr Healthy
subjects
(11)
18-36 Not Specified. Airway hypersensitivity induced by NO2 was
attenuated by pre-treatment with ascorbic
acid, relative to placebo (p < 0.04).
b) Placebo (3 days); NO2 (2.0
ppm)
c) Vitamin C (2000 mg/day for
3 days); air
d) Placebo; air
Peters,
2001,
The
Netherlands
Double-blinded;
cross over;
a) Placebo; ozone (0.4 ppm) 2 hr Intermittent
exercise
Mild atopic
asthmatics
(7)
19-26 Required a measurable plateau of
the dose-response curve to
methacholine, non smokers, no
NSAID or vitamin use during
study.
Airway hypersensitivity induced by O3 was
attenuated by pre-treatment with apocynin,
relative to placebo (p = 0.025).
b) Apocynin (12 mg); ozone
(0.4 ppm)
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1Table 1 Studies assessing effect of antioxidant supplementation on lung function associated with controlled air pollutant exposures in intact humans
(Continued)
Samet,
2001, USA
Randomized
(non-crossover);
double-blinded
a) Vitamin C-restricted diet +
placebo (2 weeks); ozone (0.4
ppm)
2 hr Exercise Healthy on
a low
ascorbate
diet
(31)
18-35 Non-smokers. Ozone-induced decrements in FEV1 and
FVC were attenuated (p = 0.046 and p =
0.055 respectively), by vitamin C and
vitamin E.
b) Vitamin C-restricted diet +
250 mg of vitamin C, 50 IU of
alpha-tocopherol, and 12 oz.
of
vegetable cocktail (2 weeks);
ozone (0.4 ppm)
c) Vitamin C-restricted diet
(1 week); air
Trenga,
2001, USA
Randomized
(crossover);
double-blinded
a) Placebo; ozone (0.12 ppm) 45 min Intermittent
exercise
Adults with
asthma
(17)
18-39 Significant decrease (at least 8%)
in FVC1 from baseline with SO2
challenge, non-smokers.
SO2-induced decrements in FEV1 and peak
expiratory flow (PEF), and FEF25-75 were
attenuated by vitamin C and vitamin E (p <
0.05).
b) 400 IU vitamin E and 500
mg
Vitamin C daily (4 weeks);
ozone (0.12 ppm)
c) Placebo; air
d) 400 IU Vitamin E and 500
mg Vitamin C daily (4 weeks);
air
Mudway,
2006,
Sweden
Randomized
(crossover);
double-blinded
a) Placebo; ozone (0.2 ppm) 2 hr Intermittent
exercise
Healthy
ozone-
sensitive
(14)
21-27 Normal lung function, negative
skin prick test, non-smokers, no
history of allergy and/or lung
disease.
No significant effect of antioxidants on
ozone-attributable decrease in FEV1 (p >
0.05).
b) 500 mg
Vitamin C with 100 mg
Vitamin E
(7 days); ozone (0.2 ppm)
c) air
* For crossover studies, each individual subjected to each condition; in non-crossover, the conditions were distributed between subjects.
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1Table 2 Studies assessing effect of antioxidant supplementation on lung function associated with ambient air pollutant exposures in intact humans
First
author,
Year,
Country
Study
design
Conditions* Pollutant
exposure
duration
Anti-oxidant (dose)
and duration
Population
(N)
Age
range
Inclusion/Exclusion
criteria
Outcome
Bucca,
1992, Italy
Randomized
(crossover);
double-
blinded
a) Placebo; 24-Hour average
[pollutant]: SO2 142-159 (mcg/
mol), total particulate 322-453
(mcg/mol), CO2 1.5-4.8 (ppm),
NO2 139-178 (mcg/mol)
2 hours in
‘acute’
protocol; 4
days in
‘chronic’
protocol
Vitamin C (2 gm) once
in ‘acute’ protocol and
vitamin C (2 gm/day)
for 4 days in ‘chronic’
protocol
Policemen
(20)
24-37 Normal lung function
tests, no history of
asthma, respiratory tract
infection in the six
weeks preceding the
study.
Pollutant-induced decrement in PC25MEF50
(airway reactivity) attenuated by vitamin C.
in ‘acute’ protocol; Pollutant-induced
decrement in PC25MEF50 attenuated by
vitamin C in ‘chronic’ protocol (p < 0.001).
Peak expiratory flow decrements also
significantly attenuated by vitamin C (but
p-value not reported).
b)Anti-oxidant; 24-Hour average
[pollutant]: SO2 142-159 (mcg/
mol), Total particulate 322-453
(mcg/mol), CO2 1.5-4.8 (ppm),
NO2 139-178 (mcg/mol)
Grievnik,
1998, The
Netherlands
Randomized a) Placebo; 8-Hour average
[ozone]: 101 (μg/m
3)
70 days Vitamin E (75 mg/day),
Vitamin C (650 mg/day)
and b-carotene (15
mg/day) for 3 months
Amateur
cyclists
(26)
16-41 Subjects with a range in
exposure to ozone of
less than 50 (μg/m
3)
were excluded for
analysis.
Ozone-associated decrements in FVC, FEV1,
and peak expiratory flow (PEF), were
attenuated by vitamin E, vitamin C and b-
carotene. No p-value provided.
b)Anti-oxidant; 8-Hour average
[ozone]: 101 (μg/m
3)
Romieu,
1998,
Mexico
Randomized
(crossover);
double-
blinded
a) Placebo; hourly average
[pollutant]: ozone 67.3 (ppb), NO2
52.3 (ppb), PM10 76.5 (μg/m
3)
with placebo
6 months Vitamin E (75 mg/day),
Vitamin C (650 mg/day)
and b-carotene (15
mg/day) for 130 days
over 2 phases
Male street
workers
(47)
18-58 Working outdoors in the
central area of Mexico
City, No more than 5
cigarettes/day.
Ozone-associated decrease in FEV1, FVC
and FEF25-75 attenuated by Vitamin C,
Vitamin E and beta-carotene. (first phase of
study p values for all 3 parameters: p <
0.01; second phase of study p values for
FVC and FEF25-75 p < 0.01 and p < 0.05 for
FEV1).
b)Anti-oxidant; hourly average
[pollutant]: ozone 67.3 (ppb),
NO2 52.3 (ppb), PM10 76.5(μg/m
3)
Grievnik,
1999, The
Netherlands
Randomized
(non-cross
over);
double-
blinded
a)Placebo; 8-Hour average
[ozone]: 84-88 (μg/m
3)
15 weeks Vitamin E (100 mg/
daily), Vitamin C (500
mg/daily) for 15 weeks
Amateur
and
recreational
cyclists
(38)
17-58 Non smokers. Ozone-associated decrease in FEV1, FVC
attenuated by Vitamin C, and Vitamin E (p
< 0.05).
b)Anti-oxidant; 8-Hour average
[ozone]: 84-88 (μg/m
3)
Romieu,
2002,
Mexico
Randomized;
double-
blinded
a) Placebo; 24-Hour average
[pollutant]: SO2 33 (ppb), PM10
56.68 (μg/m
3), NO2 30 (μg/m
3)
ozone 32 (ppb)
12 weeks Vitamin E (50 mg/day),
Vitamin C (250 mg/day)
for 12 weeks
Asthmatic
children
(158)
6-17 Not specified. Ozone-associated decrements in FEF25-75
and PEF were attenuated by vitamin E and
vitamin C (p < 0.05).
b)Anti-oxidant; 24-Hour average
[pollutant]: SO2 33 (ppb), PM10
56.68
(μg/m
3), NO2 30 (μg/m
3) ozone
32 (ppb)
* For crossover studies, each individual subjected to each condition; in non-crossover, the conditions were distributed between subjects.
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1significant (p < 0.01) decrements in FEV1 after 2 hours
of ozone exposure in all fourteen subjects; however
there were no significant effects of antioxidant supple-
mentation (vitamin C and vitamin E) on ozone-attribu-
table decrease in FEV1 (-8.5% with supplementation
v e r s u s- 7 . 3 %w i t hp l a c e b o ;p>0 . 0 5 ) .B o t hi n d e p e n d e n t
trials of Hackney et al. [26] reached a similar conclusion
after subject supplementation with varying vitamin E
doses. The first trial reported a smaller decrease in lung
function measurements (FVC, FEV1) in the supplemen-
ted group as compared to the placebo group, after 2
hours of controlled ozone exposure. More specifically,
the reported post exposure ΔFVC with placebo was
-0.22 ± 0.25 L as compared with -0.19 ± 0.40 L in the
supplemented group without a statistical significance
( t=0 . 2 5 ,p>0 . 0 5 )a n dt h er e p o r t e dp o s te x p o s u r e
ΔFEV1 with placebo was -0.27 ± 0.27 L as compared
with -0.19 ± 0.35 L in the supplemented group without
a statistical significance (t = 0.83, p > 0.05). During this
trial, authors noted that the few vitamin supplemented
male subjects demonstrated a potential beneficial effect
and hence the second trial included only male subjects
with similar exposure conditions as the first. However,
this trial too failed to report significant effects of antiox-
idant supplementation on ozone-attributable decrease in
FEV1 (p = 0.626), FVC (p = 0.661), FEF50% (p = 0.369),
FEF25% (p = 0.225), and Total Lung Capacity (TLC, p =
0.221).
Table 2 summarizes the remaining 5 studies under
ambient pollutant conditions. These studies each found
that antioxidant supplementations attenuate the negative
effects of ambient urban pollution on the lungs and air-
ways. Romieu et al. [30] supplemented forty-seven male,
Mexico city street workers with vitamin C, vitamin E
and b-carotene for six months, while recording hourly
average pollutant concentrations in an urban area in a
two phase study. For the first phase, authors concluded
that pollutant-associated decrease in FEV1,F V Ca n d
FEF25-75 are attenuated by supplementation with those
antioxidants (p < 0.01 for all three parameters). Similar
results were also reported in the second phase of the
study (p < 0.01 for FVC and FEF25-75 and p < 0.05 for
FEV1). A comparable study was conducted by Romieu
et al. in 2002 [31] with 158 asthmatic children, fol-
lowed-up for 12 weeks, as the study population. In this
study, Romieu et al. observed significant (p < 0.05) dif-
ferences in lung function decrements between supple-
mented and control groups for FEF25-75 and PEF,
concluding that ozone-associated decrements in FEF25-75
and PEF were attenuated by vitamin E and vitamin C.
Bucca et al. [32] conducted a two part study investigat-
ing both acute and long term effects of antioxidant sup-
plementation in twenty policemen. The duration of
exposure to the heavy car traffic city centre in the
‘acute’ protocol was 2 hours and this duration was 4
days in the ‘chronic’ protocol. In the first phase, authors
reported that pollutant-induced decrement in Maximal
mid-Expiratory Flow (MEF50) is attenuated by vitamin C
supplementation. FVC and FEV1 remained nearly
unchanged after NO2 exposure. In the second phase,
authors reported that during placebo treatment the
mean values of PEF were slightly but significantly
decreased after exposure and were not significantly
affected by exposure during vitamin C treatment. No
quantitative statistical significances were provided for
these results. Grievink et al. [33] reported that ozone-
associated decrements in FVC, FEV1, and PEF are atte-
nuated by vitamin C and vitamin E supplementation in
twenty six amateur cyclists. Grievink and colleagues
observed no significant effect on FVC, FEV1,P E Fa n d
MMEF (maximal mid-expiratory flow), due to an eight
hour mean ozone exposure in the supplemented group;
however all these parameters (except for MMEF) were
decremented as a result of the exposure in the control
group. Further, they reported the protective effects of
supplementation (with the 95% confidence intervals) for
each parameter as follows: FVC 2.08 (1.31 to 2.85) ml
per μg/m
3 of ozone, FEV1 1.66 (0.62 to 2.70) ml per μg/
m
3 of ozone, PEF 6.83 (3.17 to 10.49) ml per μg/m
3 of
ozone. Finally, in a randomized and double blinded
study, Grievink, et al. [34] measured lung functions of
38 “amateur and recreational” bicyclists before and after
each training session for a period of 15 weeks. They
concluded that Vitamin C and E supplementation pro-
vided a significant (p < 0.05) partial protection against
ambient ozone induced decreases in FEV1 (median Δ:
-0.95 ml per μg/m
3 of ozone for placebo and -0.01 ml
per μg/m
3 of ozone for supplemented group) and FVC
(median Δ: -1.25 ml per μg/m
3 of ozone for placebo and
-0.42 ml per μg/m
3 of ozone for supplemented group) as
compared to the placebo group.
Discussion
We specifically aimed to limit our focus, as outlined
above, based on the perceived gap between studies on
intact humans with controlled anti-oxidant supplementa-
tion and the broader literature which is informative but
is limited based on difficulties comparing human and ani-
mal physiology and/or by difficulties comparing observa-
tional and experimental studies. Our approach was
strictly systematic; a complete and relevant list of search
terms was utilized in multiple appropriate databases and
an independent application of inclusion criteria by two
authors collectively ensured the comprehensiveness of
this systematic search. Our systematic approach distin-
guishes our work, particularly from the excellent effort of
others. Romieu et al. [35] published an informative sys-
tematic review on air pollution, oxidative stress and
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systematic review; Florida-James et al. [36] discussed the
potential negative impacts of various ambient pollutant
exposures on the performance of athletes competing in
Athens 2004. The current review however represents an
update of previous reviews and is a formal and explicit
search which systematically examined the literature and
focused entirely on the potential role of anti-oxidant sup-
plementations as opposed to also discussing biological
and epidemiological evidence for the oxidative stress
inducing role of air pollutants. Accordingly, we expect
that our approach is most helpful to those considering
practical decisions and possibly guidelines, as well as
researchers considering the need for further related
work, regarding anti-oxidant supplementation to attenu-
ate air pollution effects.
An immediate consistency in results is not apparent
within studies conducted under controlled conditions
(Table 1). Even though 5 out of 8 studies in suggested a
potential benefit for antioxidant supplementation, such
results are far from unanimous and are contradicted by
interesting studies that did not make our inclusion criteria.
For example, as stated above, Mudway and colleagues [20]
subjected 30 volunteers (15 health and 15 mild asthmatics)
to 2 hours of controlled ozone exposures; they observed
that the asthmatic group had significantly (p < 0.01) lower
basal Ascorabte concentrations extracted from their proxi-
mal and distal respiratory tract lining fluid as compared
with the control group. However, this depletion in basal
antioxidant concentrations was not associated with a sig-
nificantly higher ozone induced neutrophilia or decrement
in FEV1 as compared with the control group. This sug-
gests a potential discrepancy between the roles of supple-
mented antioxidants compared to basal concentrations
and warrants future studies to differentiate distinguished
benefits from each.
Despite the small number of studies conducted to date
that fall within our inclusion criteria, the general consis-
tency of studies in Table 2, compromising of research
conducted in ambient pollution conditions is note-
worthy. Arguably, these studies provide the most
directly interpretable results, in terms of implementation
of available data in public health recommendations; all
such studies reported uncontrolled (ambient) pollutant
conditions that were directly representative of daily life
in these locations. Such realistic exposures are more
representative and informative than studies conducted
under controlled exposure conditions, such as those in
Table 1. All of the uncontrolled exposure studies con-
cluded that a potential benefit for antioxidant supple-
mentation in attenuating the negative effects of air
pollution is evident; these findings are consistent with
previous studies investigatin gt h er o l eo fv a r i o u sa n t i -
inflammatory interventions, for example azithromycin
[37], indomethacin [38], cyclooxygenase metabolites [39]
and budesonide [40] on pollution induced lung out-
come. However, such consistency does not refute the
need for more research on the subject. For example, of
all the studies in Table 2, only one study [32] analysed
the role of antioxidant supplementation on attenuating
the negative health effects of combined exposure to
measured pollutants. In other words, all other studies
only focused on the ability of supplements to lessen the
effects of only one of the measured pollutants (such as
ozone), even though in reality humans are continuously
exposed to combined levels of all relevant pollutants
and research with public health applicability necessities
an investigation of the combined effects of these pollu-
tants and the potential role of supplementation. Further-
more, the lack of personal exposure data in most studies
is problematic in that exposure misclassification may
occur under such circumstances. Finally, Grievink [33]
was the only study that focused particularly on the
effects of outdoor particulate matter (PM) exposure,
despite significant morbidity and mortality associated
with such exposures as outlined above [1].
Conclusions
Of the 13 studies that were reviewed for the current
study, vitamin C, Vitamin E and B-carotene were exam-
ined for their roles in attenuating the adverse effects of
pollutant. There were conflicting results based on the
varying controlled and uncontrolled exposures, yet there
was a trend for potential benefit for antioxidant supple-
mentation in ten of the 13 studies. Meanwhile the
effects on morbidity and mortality are still unclear.
Therefore future research in humans will need to focus
on selecting appropriate exposure materials and length
of time to quantify the benefits of antioxidant
supplementation.
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